Thomas Bold is the President and CEO of RenovaCare. RenovaCare is developing first-of-their-kind therapies for regenerating human organs by using a patient’s own stem cells. With extensive business experience in biotechnology, device manufacturing, stem cell research and regenerative medicine, Thomas is streamlining RenovaCare’s flagship technology, the SkinGun.

The SkinGun is a revolutionary technology that uses a novel spray system to ultra-gently ‘mist’ a patient’s stem cells on to wounds and severe burns, healing them virtually scar-free. In this episode of MedTech Chat, Thomas will discuss RenovaCare’s breakthrough technology for regenerating the skin.